These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


132 related items for PubMed ID: 19794380

  • 1. Management of totally implantable vascular access devices in patients with cystic fibrosis.
    Dal Molin A, Gatta C, Festini F.
    Minerva Pediatr; 2009 Oct; 61(5):549-55. PubMed ID: 19794380
    [Abstract] [Full Text] [Related]

  • 2. Seat belt associated central line fracture--a previously unreported complication in cystic fibrosis.
    Ghayyda SN, Roland D, Cade A.
    J Cyst Fibros; 2008 Sep; 7(5):448-9. PubMed ID: 18455967
    [Abstract] [Full Text] [Related]

  • 3. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer.
    Beckers MM, Ruven HJ, Seldenrijk CA, Prins MH, Biesma DH.
    Thromb Res; 2010 Apr; 125(4):318-21. PubMed ID: 19640573
    [Abstract] [Full Text] [Related]

  • 4. ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications).
    Pittiruti M, Hamilton H, Biffi R, MacFie J, Pertkiewicz M, ESPEN.
    Clin Nutr; 2009 Aug; 28(4):365-77. PubMed ID: 19464090
    [Abstract] [Full Text] [Related]

  • 5. Guidelines for the management of intravascular catheter-related infections.
    Mermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS, Craven DE, Infectious Diseases Society of America, American College of Critical Care Medicine, Society for Healthcare Epidemiology of America.
    J Intraven Nurs; 2001 Aug; 24(3):180-205. PubMed ID: 11530364
    [Abstract] [Full Text] [Related]

  • 6. [Infectious and non-infectious complications of tunneled central catheters in hematologic patients].
    Albo López C, López Rodríguez D, Constenla Camba MI, Jimenéz Blanco A, Araujo LF, García-Medina J.
    Sangre (Barc); 1999 Jun; 44(3):176-81. PubMed ID: 10481577
    [Abstract] [Full Text] [Related]

  • 7. Peripherally inserted central catheters (PICCs) in the CF population: one center's experience.
    Tolomeo C, Mackey W.
    Pediatr Nurs; 2003 Jun; 29(5):355-9. PubMed ID: 14651306
    [Abstract] [Full Text] [Related]

  • 8. Experience of totally implantable venous access devices (TIV ADs) in adults with cystic fibrosis over a 13-year period.
    Kariyawasam HH, Pepper JR, Hodson ME, Geddes DM.
    Respir Med; 2000 Dec; 94(12):1161-5. PubMed ID: 11192950
    [Abstract] [Full Text] [Related]

  • 9. Totally implantable central venous access devices in adult oncological patients.
    Florio G, Del Papa M, Mari A, Carnì D.
    Chir Ital; 2008 Dec; 60(5):697-702. PubMed ID: 19062492
    [Abstract] [Full Text] [Related]

  • 10. Stuck long-term indwelling central venous catheters in adolescents: three cases and a short topical review.
    Mortensen A, Afshari A, Henneberg SW, Hansen MA.
    Acta Anaesthesiol Scand; 2010 Jul; 54(6):777-80. PubMed ID: 20455871
    [Abstract] [Full Text] [Related]

  • 11. Identifying complications of central venous catheters: infection, thrombosis, occlusion.
    Prescrire Int; 2009 Aug; 18(102):173-4. PubMed ID: 19746562
    [Abstract] [Full Text] [Related]

  • 12. Superior vena cava syndrome related to indwelling intravenous catheters in patients with cystic fibrosis.
    Garwood S, Flume PA, Ravenel J.
    Pediatr Pulmonol; 2006 Jul; 41(7):683-7. PubMed ID: 16703584
    [Abstract] [Full Text] [Related]

  • 13. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
    Schumm K, Lam TB.
    Neurourol Urodyn; 2008 Jul; 27(8):738-46. PubMed ID: 18951451
    [Abstract] [Full Text] [Related]

  • 14. Infection of totally implantable venous access devices: A review of the literature.
    Pinelli F, Cecero E, Degl'Innocenti D, Selmi V, Giua R, Villa G, Chelazzi C, Romagnoli S, Pittiruti M.
    J Vasc Access; 2018 May; 19(3):230-242. PubMed ID: 29512430
    [Abstract] [Full Text] [Related]

  • 15. Advances in venous access devices and nursing management strategies.
    Wickham RS.
    Nurs Clin North Am; 1990 Jun; 25(2):345-64. PubMed ID: 2110664
    [Abstract] [Full Text] [Related]

  • 16. Peripheral infusion ports for central venous access in patients with gynecologic malignancies.
    Cunningham MJ, Collins MB, Kredentser DC, Malfetano JH.
    Gynecol Oncol; 1996 Mar; 60(3):397-9. PubMed ID: 8774645
    [Abstract] [Full Text] [Related]

  • 17. Venous access ports: frequency and management of complications in oncology patients.
    Jordan K, Behlendorf T, Surov A, Kegel T, Maher G, Wolf HH.
    Onkologie; 2008 Jul; 31(7):404-10. PubMed ID: 18596390
    [Abstract] [Full Text] [Related]

  • 18. Increased use of percutaneous technique for totally implantable venous access devices. Is it real progress? A 27-year comprehensive review on early complications.
    Di Carlo I, Pulvirenti E, Mannino M, Toro A.
    Ann Surg Oncol; 2010 Jun; 17(6):1649-56. PubMed ID: 20204533
    [Abstract] [Full Text] [Related]

  • 19. Do central venous catheters have advantages over arteriovenous fistulas or grafts?
    Quarello F, Forneris G, Borca M, Pozzato M.
    J Nephrol; 2006 Jun; 19(3):265-79. PubMed ID: 16874685
    [Abstract] [Full Text] [Related]

  • 20. Management of infections related to totally implantable venous-access ports: challenges and perspectives.
    Lebeaux D, Fernández-Hidalgo N, Chauhan A, Lee S, Ghigo JM, Almirante B, Beloin C.
    Lancet Infect Dis; 2014 Feb; 14(2):146-59. PubMed ID: 24314751
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.